Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 274

1.

KofamKOALA: KEGG ortholog assignment based on profile HMM and adaptive score threshold.

Aramaki T, Blanc-Mathieu R, Endo H, Ohkubo K, Kanehisa M, Goto S, Ogata H.

Bioinformatics. 2019 Nov 19. pii: btz859. doi: 10.1093/bioinformatics/btz859. [Epub ahead of print]

PMID:
31742321
2.

The minimal gap-junction network among melanophores and xanthophores required for stripe pattern formation in zebrafish.

Usui Y, Aramaki T, Kondo S, Watanabe M.

Development. 2019 Nov 15;146(22). pii: dev181065. doi: 10.1242/dev.181065.

PMID:
31666235
3.

Prognostic role of the length of tumour-vein contact at the portal-superior mesenteric vein in patients having surgery for pancreatic cancer.

Imamura T, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, Todaka A, Fukutomi A, Aramaki T, Uesaka K.

Br J Surg. 2019 Nov;106(12):1649-1656. doi: 10.1002/bjs.11328. Epub 2019 Oct 18.

PMID:
31626342
4.

Prediction of Portal Vein Thrombosis Following Hepatectomy for Perihilar Cholangiocarcinoma: Efficacy of Postoperative Portal Vein Diameter Ratio and Angle.

Uchida T, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, Aramaki T, Uesaka K.

Anticancer Res. 2019 Sep;39(9):5019-5026. doi: 10.21873/anticanres.13692.

PMID:
31519609
5.

A randomized, controlled trial of the efficacy of percutaneous transesophageal gastro-tubing (PTEG) as palliative care for patients with malignant bowel obstruction: the JIVROSG0805 trial.

Aramaki T, Arai Y, Takeuchi Y, Sone M, Sato R, Bekku E, Moriguchi M.

Support Care Cancer. 2019 Sep 7. doi: 10.1007/s00520-019-05066-8. [Epub ahead of print]

PMID:
31494734
6.

Benign Portal Vein Stenosis After Pancreaticoduodenectomy.

Ohgi K, Sugiura T, Yamamoto Y, Okamura Y, Ito T, Ashida R, Aramaki T, Uesaka K.

World J Surg. 2019 Oct;43(10):2623-2630. doi: 10.1007/s00268-019-05070-3.

PMID:
31243526
7.

Pancreatic attenuation on computed tomography predicts pancreatic fistula after pancreaticoduodenectomy.

Ohgi K, Okamura Y, Sugiura T, Ito T, Yamamoto Y, Ashida R, Aramaki T, Uesaka K.

HPB (Oxford). 2019 Jun 19. pii: S1365-182X(19)30558-1. doi: 10.1016/j.hpb.2019.05.008. [Epub ahead of print]

PMID:
31229490
8.

Integration of an Academic Medical Center and a Large Health System: Implications for Pharmacy.

Erstad BL, Aramaki T, Weibel K.

Hosp Pharm. 2019 Jun;54(3):170-174. doi: 10.1177/0018578718823735. Epub 2019 Jan 10.

PMID:
31205327
9.

Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL).

Hidaka H, Izumi N, Aramaki T, Ikeda M, Inaba Y, Imanaka K, Okusaka T, Kanazawa S, Kaneko S, Kora S, Saito H, Furuse J, Matsui O, Yamashita T, Yokosuka O, Morita S, Arioka H, Kudo M, Arai Y.

Med Oncol. 2019 May 3;36(6):52. doi: 10.1007/s12032-019-1272-2.

PMID:
31053989
10.

The tumor diameter cut-off for predicting microscopic intrahepatic metastasis of hepatocellular carcinoma patients without treatment history differs from that of hepatocellular carcinoma patients with a treatment history.

Okamura Y, Sugiura T, Ito T, Yamamoto Y, Ashida R, Aramaki T, Uesaka K.

Clin Transl Oncol. 2019 Apr 30. doi: 10.1007/s12094-019-02120-z. [Epub ahead of print]

PMID:
31041718
11.

Clinical features and human T-cell leukemia virus type-1 (HTLV-1) proviral load in HTLV-1-positive patients with rheumatoid arthritis: Baseline data in a single center cohort study.

Eguchi K, Iwanaga M, Terada K, Aramaki T, Tuji Y, Kurushima S, Kojima K, Arima K, Iwamoto N, Ichinose K, Kawakami A, Hirakata N, Ueki Y.

Mod Rheumatol. 2019 Apr 2:1-10. doi: 10.1080/14397595.2019.1602931. [Epub ahead of print]

PMID:
30938551
12.

Erratum: First Dark Matter Constraints from a SuperCDMS Single-Charge Sensitive Detector [Phys. Rev. Lett. 121, 051301 (2018)].

Agnese R, Aralis T, Aramaki T, Arnquist IJ, Azadbakht E, Baker W, Banik S, Barker D, Bauer DA, Binder T, Bowles MA, Brink PL, Bunker R, Cabrera B, Calkins R, Cartaro C, Cerdeño DG, Chang YY, Cooley J, Cornell B, Cushman P, Di Stefano PCF, Doughty T, Fascione E, Figueroa-Feliciano E, Fink C, Fritts M, Gerbier G, Germond R, Ghaith M, Golwala SR, Harris HR, Hong Z, Hoppe EW, Hsu L, Huber ME, Iyer V, Jardin D, Jena C, Kelsey MH, Kennedy A, Kubik A, Kurinsky NA, Lawrence RE, Leyva JV, Loer B, Lopez Asamar E, Lukens P, MacDonell D, Mahapatra R, Mandic V, Mast N, Miller EH, Mirabolfathi N, Mohanty B, Morales Mendoza JD, Nelson J, Orrell JL, Oser SM, Page WA, Partridge R, Pepin M, Phipps A, Ponce F, Poudel S, Pyle M, Qiu H, Rau W, Reisetter A, Reynolds T, Roberts A, Robinson AE, Rogers HE, Romani RK, Saab T, Sadoulet B, Sander J, Scarff A, Schnee RW, Scorza S, Senapati K, Serfass B, So J, Speller D, Stanford C, Stein M, Street J, Tanaka HA, Toback D, Underwood R, Villano AN, von Krosigk B, Watkins SL, Wilson JS, Wilson MJ, Winchell J, Wright DH, Yellin S, Young BA, Zhang X, Zhao X.

Phys Rev Lett. 2019 Feb 15;122(6):069901. doi: 10.1103/PhysRevLett.122.069901.

PMID:
30822060
13.

Efficacy of infliximab as a switched biologic in rheumatoid arthritis patients in daily clinical practice.

Umeda M, Koga T, Ichinose K, Takatani A, Igawa T, Shimizu T, Fukui S, Nishino A, Horai Y, Hirai Y, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Aramaki T, Ueki Y, Okada A, Fujikawa K, Matsuoka N, Kawakami A.

Immunol Med. 2018 Dec;41(4):181-186. doi: 10.1080/25785826.2018.1542942. Epub 2019 Jan 11.

PMID:
30632931
14.

A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors.

Doi T, Aramaki T, Yasui H, Muro K, Ikeda M, Okusaka T, Inaba Y, Nakai K, Ikezawa H, Nakajima R.

Invest New Drugs. 2019 Oct;37(5):1061-1074. doi: 10.1007/s10637-018-0713-7. Epub 2019 Jan 9.

15.

Method for disarranging the pigment pattern of zebrafish by optogenetics.

Aramaki T, Kondo S.

Dev Biol. 2018 Dec 19. pii: S0012-1606(18)30467-6. doi: 10.1016/j.ydbio.2018.12.019. [Epub ahead of print]

PMID:
30578760
16.

Phase II Trial of Transarterial Embolization Using an n-Butyl-2-Cyanoacrylate/Lipiodol Mixture (JIVROSG-0802).

Sugawara S, Arai Y, Sone M, Ishiguchi T, Kitagawa A, Aramaki T, Sato R, Morishita H, Takeuchi Y, Inaba Y.

Cardiovasc Intervent Radiol. 2019 Apr;42(4):534-541. doi: 10.1007/s00270-018-2141-7. Epub 2018 Dec 6.

PMID:
30523386
17.

Clinical predictors of inadequate response to conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) including methotrexate (MTX) in untreated rheumatoid arthritis patients -A single-center observational study.

Aramaki T, Ueki Y, Kojima K, Kurushima S, Tsuji Y, Kawachi N, Iwamoto N, Ichinose K, Terada K, Eguchi K, Kawakami A.

Mod Rheumatol. 2018 Nov 28:1-18. doi: 10.1080/14397595.2018.1553265. [Epub ahead of print]

PMID:
30482075
18.

Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients.

Tak WY, Ryoo BY, Lim HY, Kim DY, Okusaka T, Ikeda M, Hidaka H, Yeon JE, Mizukoshi E, Morimoto M, Lee MA, Yasui K, Kawaguchi Y, Heo J, Morita S, Kim TY, Furuse J, Katayama K, Aramaki T, Hara R, Kimura T, Nakamura O, Kudo M.

Invest New Drugs. 2018 Dec;36(6):1072-1084. doi: 10.1007/s10637-018-0658-x. Epub 2018 Sep 10.

PMID:
30198057
19.

The Radiological Differentiation of Hypervascular Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma with a Focus on the CT Value on Multi-phase Enhanced CT.

Sano S, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, Aramaki T, Nakanuma Y, Uesaka K.

Anticancer Res. 2018 Sep;38(9):5505-5512. doi: 10.21873/anticanres.12884.

PMID:
30194209
20.

Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs.

Iwamoto N, Okamoto M, Tsuji S, Endo Y, Takatani A, Shimizu T, Umeda M, Fukui S, Sumiyoshi R, Igawa T, Koga T, Kawashiri SY, Aramaki T, Ichinose K, Tamai M, Nakamura H, Origuchi T, Eguchi K, Ueki Y, Kawakami A.

J Bone Miner Metab. 2019 May;37(3):554-562. doi: 10.1007/s00774-018-0955-7. Epub 2018 Sep 5.

PMID:
30187273
21.

First Dark Matter Constraints from a SuperCDMS Single-Charge Sensitive Detector.

Agnese R, Aralis T, Aramaki T, Arnquist IJ, Azadbakht E, Baker W, Banik S, Barker D, Bauer DA, Binder T, Bowles MA, Brink PL, Bunker R, Cabrera B, Calkins R, Cartaro C, Cerdeño DG, Chang YY, Cooley J, Cornell B, Cushman P, Di Stefano PCF, Doughty T, Fascione E, Figueroa-Feliciano E, Fink C, Fritts M, Gerbier G, Germond R, Ghaith M, Golwala SR, Harris HR, Hong Z, Hoppe EW, Hsu L, Huber ME, Iyer V, Jardin D, Jena C, Kelsey MH, Kennedy A, Kubik A, Kurinsky NA, Lawrence RE, Leyva JV, Loer B, Lopez Asamar E, Lukens P, MacDonell D, Mahapatra R, Mandic V, Mast N, Miller EH, Mirabolfathi N, Mohanty B, Morales Mendoza JD, Nelson J, Orrell JL, Oser SM, Page WA, Partridge R, Pepin M, Phipps A, Ponce F, Poudel S, Pyle M, Qiu H, Rau W, Reisetter A, Reynolds T, Roberts A, Robinson AE, Rogers HE, Romani RK, Saab T, Sadoulet B, Sander J, Scarff A, Schnee RW, Scorza S, Senapati K, Serfass B, So J, Speller D, Stanford C, Stein M, Street J, Tanaka HA, Toback D, Underwood R, Villano AN, von Krosigk B, Watkins SL, Wilson JS, Wilson MJ, Winchell J, Wright DH, Yellin S, Young BA, Zhang X, Zhao X.

Phys Rev Lett. 2018 Aug 3;121(5):051301. doi: 10.1103/PhysRevLett.121.051301. Erratum in: Phys Rev Lett. 2019 Feb 15;122(6):069901.

22.

Evaluation of stent placement for vena cava syndrome: phase II trial and phase III randomized controlled trial.

Takeuchi Y, Arai Y, Sone M, Sugawara S, Aramaki T, Sato R, Kichikawa K, Tanaka T, Morishita H, Ito T, Yamakado K, Baba Y, Kobayashi T.

Support Care Cancer. 2019 Mar;27(3):1081-1088. doi: 10.1007/s00520-018-4397-5. Epub 2018 Aug 15.

PMID:
30112721
23.

Propensity score-matched comparison of non-anatomical resection and radiofrequency ablation for hepatocellular carcinoma in patients with up to three tumours, each measuring up to 3 cm in diameter.

Kato Y, Okamura Y, Omae K, Sugiura T, Ito T, Yamamoto Y, Ashida R, Sato R, Aramaki T, Uesaka K.

BJS Open. 2018 May 28;2(4):213-219. doi: 10.1002/bjs5.60. eCollection 2018 Aug.

24.

Current status of the megabenthic community in coastal Fukushima Prefecture, Japan, in the wake of the Great East Japan Earthquake.

Kodama K, Aramaki T, Horiguchi T.

Mar Environ Res. 2018 Sep;140:358-374. doi: 10.1016/j.marenvres.2018.07.005. Epub 2018 Jul 10.

PMID:
30025816
25.

Hepatic Arterial Infusion Chemotherapy: A Potential Therapeutic Option for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

Moriguchi M, Aramaki T, Tanaka T, Itoh Y.

Liver Cancer. 2018 May;7(2):209-210. doi: 10.1159/000488156. Epub 2018 Apr 20. No abstract available.

26.

The Predictors of Microscopic Vessel Invasion Differ Between Primary Hepatocellular Carcinoma and Hepatocellular Carcinoma with a Treatment History.

Okamura Y, Sugiura T, Ito T, Yamamoto Y, Ashida R, Aramaki T, Uesaka K.

World J Surg. 2018 Nov;42(11):3694-3704. doi: 10.1007/s00268-018-4658-y.

PMID:
29872870
27.

Flexibility of pigment cell behavior permits the robustness of skin pattern formation.

Sawada R, Aramaki T, Kondo S.

Genes Cells. 2018 Jul;23(7):537-545. doi: 10.1111/gtc.12596. Epub 2018 May 23. Erratum in: Genes Cells. 2019 Mar;24(3):266.

28.

Clinical trial for development of a steerable microcatheter.

Inaba Y, Arai Y, Sone M, Aramaki T, Osuga K, Tanaka H, Kanemasa K.

Minim Invasive Ther Allied Technol. 2019 Feb;28(1):1-5. doi: 10.1080/13645706.2018.1467458. Epub 2018 Apr 27.

PMID:
29703107
29.

Late benign biliary complications after pancreatoduodenectomy.

Ito T, Sugiura T, Okamura Y, Yamamoto Y, Ashida R, Aramaki T, Endo M, Matsubayashi H, Ishiwatari H, Uesaka K.

Surgery. 2018 Jun;163(6):1295-1300. doi: 10.1016/j.surg.2018.02.015. Epub 2018 Apr 21.

PMID:
29685633
30.

Phase I/II Study of Radiofrequency Ablation for Painful Bone Metastases: Japan Interventional Radiology in Oncology Study Group 0208.

Tanigawa N, Arai Y, Yamakado K, Aramaki T, Inaba Y, Kanazawa S, Matsui O, Miyazaki M, Kodama Y, Anai H, Hamanaka A.

Cardiovasc Intervent Radiol. 2018 Jul;41(7):1043-1048. doi: 10.1007/s00270-018-1944-x. Epub 2018 Apr 12.

PMID:
29675772
31.

Radiocesium in seawater, sediments, and marine megabenthic species in coastal waters off Fukushima in 2012-2016, after the 2011 nuclear disaster.

Horiguchi T, Kodama K, Aramaki T, Miyata Y, Nagao S.

Mar Environ Res. 2018 Jun;137:206-224. doi: 10.1016/j.marenvres.2018.03.014. Epub 2018 Mar 30.

PMID:
29628392
32.

A predictive scoring system for insufficient liver hypertrophy after preoperative portal vein embolization.

Watanabe N, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Aramaki T, Uesaka K.

Surgery. 2018 May;163(5):1014-1019. doi: 10.1016/j.surg.2017.11.026. Epub 2018 Feb 28.

PMID:
29501348
33.

Results from the Super Cryogenic Dark Matter Search Experiment at Soudan.

Agnese R, Aramaki T, Arnquist IJ, Baker W, Balakishiyeva D, Banik S, Barker D, Basu Thakur R, Bauer DA, Binder T, Bowles MA, Brink PL, Bunker R, Cabrera B, Caldwell DO, Calkins R, Cartaro C, Cerdeño DG, Chang Y, Chen Y, Cooley J, Cornell B, Cushman P, Daal M, Di Stefano PCF, Doughty T, Fascione E, Figueroa-Feliciano E, Fritts M, Gerbier G, Germond R, Ghaith M, Godfrey GL, Golwala SR, Hall J, Harris HR, Hong Z, Hoppe EW, Hsu L, Huber ME, Iyer V, Jardin D, Jastram A, Jena C, Kelsey MH, Kennedy A, Kubik A, Kurinsky NA, Loer B, Lopez Asamar E, Lukens P, MacDonell D, Mahapatra R, Mandic V, Mast N, Miller EH, Mirabolfathi N, Mohanty B, Morales Mendoza JD, Nelson J, Orrell JL, Oser SM, Page K, Page WA, Partridge R, Penalver Martinez M, Pepin M, Phipps A, Poudel S, Pyle M, Qiu H, Rau W, Redl P, Reisetter A, Reynolds T, Roberts A, Robinson AE, Rogers HE, Saab T, Sadoulet B, Sander J, Schneck K, Schnee RW, Scorza S, Senapati K, Serfass B, Speller D, Stein M, Street J, Tanaka HA, Toback D, Underwood R, Villano AN, von Krosigk B, Welliver B, Wilson JS, Wilson MJ, Wright DH, Yellin S, Yen JJ, Young BA, Zhang X, Zhao X; SuperCDMS Collaboration.

Phys Rev Lett. 2018 Feb 9;120(6):061802. doi: 10.1103/PhysRevLett.120.061802.

34.

A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class.

Suzuki E, Kaneko S, Okusaka T, Ikeda M, Yamaguchi K, Sugimoto R, Aramaki T, Asagi A, Yasui K, Sano K, Hosokawa A, Kato N, Ishii H, Sato T, Furuse J.

Jpn J Clin Oncol. 2018 Apr 1;48(4):317-321. doi: 10.1093/jjco/hyy010.

PMID:
29474553
35.

Brief Report: Attenuated Effectiveness of Tumor Necrosis Factor Inhibitors for Anti-Human T Lymphotropic Virus Type I Antibody-Positive Rheumatoid Arthritis.

Suzuki T, Fukui S, Umekita K, Miyamoto J, Umeda M, Nishino A, Okada A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Fujikawa K, Aramaki T, Mizokami A, Matsuoka N, Ueki Y, Eguchi K, Sato S, Hidaka T, Origuchi T, Okayama A, Kawakami A, Nakamura H.

Arthritis Rheumatol. 2018 Jul;70(7):1014-1021. doi: 10.1002/art.40461. Epub 2018 May 25.

36.

Bile duct angulation and tumor vascularity are useful radiographic features for differentiating pancreatic head cancer and intrapancreatic bile duct cancer.

Kohga A, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Aramaki T, Sasaki K, Uesaka K.

Surg Today. 2018 Jul;48(7):673-679. doi: 10.1007/s00595-018-1642-y. Epub 2018 Feb 19.

PMID:
29460125
37.

Hepatitis B virus reactivation in patients with rheumatoid arthritis: A single-center study.

Matsuzaki T, Eguchi K, Nagao N, Tsuji S, Aramaki T, Terada K, Iwatsu S, Tokimura I, Kamo Y, Oda H, Kinoshita N, Miyaaki H, Taura N, Ichikawa T, Kawakami A, Nakao K, Ueki Y.

Mod Rheumatol. 2018 Sep;28(5):808-813. doi: 10.1080/14397595.2017.1419842. Epub 2018 Jan 22.

PMID:
29256314
38.

Sorafenib versus Hepatic Arterial Infusion Chemotherapy as Initial Treatment for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombosis.

Moriguchi M, Aramaki T, Nishiofuku H, Sato R, Asakura K, Yamaguchi K, Tanaka T, Endo M, Itoh Y.

Liver Cancer. 2017 Nov;6(4):275-286. doi: 10.1159/000473887. Epub 2017 Aug 29.

39.

Spatial variations of 226Ra, 228Ra, 134Cs, and 137Cs concentrations in western and southern waters off the Korean Peninsula in July 2014.

Inoue M, Shirotani Y, Nagao S, Aramaki T, Kim YI, Hayakawa K.

J Environ Radioact. 2018 Feb;182:151-156. doi: 10.1016/j.jenvrad.2017.11.020. Epub 2017 Dec 8.

PMID:
29227877
40.

CD4+ CD52lo T-cell expression contributes to the development of systemic lupus erythematosus.

Umeda M, Koga T, Ichinose K, Igawa T, Sato T, Takatani A, Shimizu T, Fukui S, Nishino A, Horai Y, Hirai Y, Kawashiri SY, Iwamoto N, Aramaki T, Tamai M, Nakamura H, Yamamoto K, Abiru N, Origuchi T, Ueki Y, Kawakami A.

Clin Immunol. 2018 Feb;187:50-57. doi: 10.1016/j.clim.2017.10.004. Epub 2017 Oct 13.

PMID:
29031579
41.

Experiments for the Development of a Steerable Microcatheter.

Inaba Y, Arai Y, Sone M, Aramaki T, Osuga K, Tanaka H, Kanemasa K.

Cardiovasc Intervent Radiol. 2017 Dec;40(12):1921-1926. doi: 10.1007/s00270-017-1789-8. Epub 2017 Sep 6.

PMID:
28879604
42.

Is Pancreatic Head Cancer with Portal Venous Involvement Really Borderline Resectable? Appraisal of an Upfront Surgery Series.

Ohgi K, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Aramaki T, Uesaka K.

Ann Surg Oncol. 2017 Sep;24(9):2752-2761. doi: 10.1245/s10434-017-5972-6. Epub 2017 Jul 6.

PMID:
28685356
43.

The Pitfalls of Left Trisectionectomy or Central Bisectionectomy for Biliary Cancer: Anatomical Classification Based on the Ventral Branches of Segment VI Portal Vein Relative to the Right Hepatic Vein.

Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Aramaki T, Uesaka K.

J Gastrointest Surg. 2017 Sep;21(9):1453-1462. doi: 10.1007/s11605-017-3486-y. Epub 2017 Jun 30.

PMID:
28667434
44.

Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlled.

Kawashiri SY, Fujikawa K, Nishino A, Okada A, Aramaki T, Shimizu T, Umeda M, Fukui S, Suzuki T, Koga T, Iwamoto N, Ichinose K, Tamai M, Mizokami A, Nakamura H, Origuchi T, Ueki Y, Aoyagi K, Maeda T, Kawakami A.

Arthritis Res Ther. 2017 May 25;19(1):108. doi: 10.1186/s13075-017-1320-2.

45.

Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan.

Koga T, Okada A, Fukuda T, Hidaka T, Ishii T, Ueki Y, Kodera T, Nakashima M, Takahashi Y, Honda S, Horai Y, Watanabe R, Okuno H, Aramaki T, Izumiyama T, Takai O, Miyashita T, Sato S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Origuchi T, Nakamura H, Aoyagi K, Eguchi K, Kawakami A; Japanese RA Patients with RRP Study Group.

PLoS One. 2017 May 15;12(5):e0175281. doi: 10.1371/journal.pone.0175281. eCollection 2017.

46.

Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis.

Iwamoto N, Tsuji S, Takatani A, Shimizu T, Fukui S, Umeda M, Nishino A, Horai Y, Koga T, Kawashiri SY, Aramaki T, Ichinose K, Hirai Y, Tamai M, Nakamura H, Terada K, Origuchi T, Eguchi K, Ueki Y, Kawakami A.

PLoS One. 2017 May 4;12(5):e0177057. doi: 10.1371/journal.pone.0177057. eCollection 2017.

47.

Age estimation by ossification of thyroid cartilage of Japanese males using Bayesian analysis of postmortem CT images.

Aramaki T, Ikeda T, Usui A, Funayama M.

Leg Med (Tokyo). 2017 Mar;25:29-35. doi: 10.1016/j.legalmed.2016.12.001. Epub 2016 Dec 28.

PMID:
28457507
48.

"Direct MPR": A Useful Tool for Oblique CT Fluoroscopy-Assisted Puncture.

Sato R, Aramaki T, Yoza K, Iwai K, Moriguchi M, Asakura K, Endo M, Ito T.

Cardiovasc Intervent Radiol. 2017 Aug;40(8):1261-1266. doi: 10.1007/s00270-017-1642-0. Epub 2017 Apr 24.

PMID:
28439625
49.

The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer.

Ito T, Sugiura T, Okamura Y, Yamamoto Y, Ashida R, Aramaki T, Endo M, Uesaka K.

Pancreatology. 2017 May - Jun;17(3):451-456. doi: 10.1016/j.pan.2017.03.001. Epub 2017 Mar 8.

PMID:
28298257
50.

Vascularity and Tumor Size are Significant Predictors for Recurrence after Resection of a Pancreatic Neuroendocrine Tumor.

Yamamoto Y, Okamura Y, Uemura S, Sugiura T, Ito T, Ashida R, Kato Y, Ohgi K, Yamada M, Sasaki K, Aramaki T, Uesaka K.

Ann Surg Oncol. 2017 Aug;24(8):2363-2370. doi: 10.1245/s10434-017-5823-5. Epub 2017 Mar 7.

PMID:
28271173

Supplemental Content

Loading ...
Support Center